Related Experiment Video
Updated: May 1, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Prognostic value of bleeding after percutaneous coronary intervention in patients with diabetes
Gjin Ndrepepa1, Stefanie Schulz, Franz-Josef Neumann
1Deutsches Herzzentrum München, Munich, Germany.
Insights
Bleeding after percutaneous coronary intervention (PCI) significantly increases one-year mortality risk in patients with type 2 diabetes. This finding highlights the importance of managing bleeding events post-PCI for improved patient outcomes.
Area of Science:
- Cardiology
- Diabetology
- Vascular Medicine
Background:
- Percutaneous coronary intervention (PCI) is a common procedure for managing coronary artery disease.
- Patients with type 2 diabetes are at higher risk for cardiovascular events and complications, including bleeding.
- The impact of bleeding post-PCI on mortality in diabetic patients requires further elucidation.
Purpose of the Study:
- To evaluate the association between bleeding events following PCI and one-year mortality in patients with type 2 diabetes.
- To differentiate the mortality risk associated with access-site versus non-access-site bleeding.
Main Methods:
- A retrospective analysis of 4,329 patients with type 2 diabetes who underwent PCI.
- Bleeding events were classified using Bleeding Academic Research Consortium (BARC) criteria.
- One-year mortality was the primary outcome, with analysis of access-site and non-access-site bleeds.
Main Results:
- 10.9% of patients experienced bleeding events post-PCI.
- Bleeding was associated with a significantly higher one-year mortality (9.6% vs. 4.0%, adjusted HR=2.04).
- Non-access-site bleeding (OR=3.45) and access-site bleeding (OR=1.90) both independently increased mortality risk.
Conclusions:
- Bleeding within 30 days after PCI is a significant predictor of increased one-year mortality in diabetic patients.
- Minimizing bleeding complications post-PCI is crucial for improving survival rates in this high-risk population.
- Bleeding events enhance the predictive accuracy of mortality risk models in diabetic patients undergoing PCI.
Aims:
The aim of this study was to assess the impact of bleeding after percutaneous coronary intervention (PCI) on the outcome of patients with type 2 diabetes.
Methods And Results:
This study included 4,329 diabetic patients who underwent PCI. Bleeding was assessed using the Bleeding Academic Research Consortium criteria. The primary outcome was one-year mortality. Bleeding events occurred in 474 patients (10.9%). Access-site and non-access-site bleeds occurred in 274 patients (58%) and 200 patients (42%), respectively. Within the first year after PCI there were 198 deaths: 45 deaths (9.6%) among patients with bleeding and 153 deaths (4.0%) among patients without bleeding (adjusted hazard ratio=2.04 [95% confidence interval 1.38-3.00], p<0.001). There were 25 deaths (12.7%) among patients with non-access-site bleeding and 20 deaths (7.4%) among patients with access-site bleeding (odds ratio [OR]=3.45 [2.20-5.41], p<0.001 for non-access-site bleeding vs. no bleeding and OR=1.90 [1.17-3.01], p=0.008 for access-site bleeding vs. no bleeding). Bleeding improved the discriminatory power of the multivariable model for mortality prediction (p=0.002).
Conclusions:
In patients with diabetes undergoing PCI, occurrence of bleeding within the first 30 days after PCI was associated with a significant increase in the risk of one-year mortality.
More Related Videos
Related Concept Videos
Diabetic Retinopathy
Peripheral Artery Disease V: Postoperative Nursing Management
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

